Therapy-Related Myelodysplastic Syndrome Recruiting Phase 1 / 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01823198Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid MalignanciesTreatment